VivoSeq
Other

Rectus Sheath Block

0

Pipeline Programs

2

Active Trials

0

Companies Involved

Rectus Sheath Block is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

85/100

Attrition Rate

12/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

17

clinical trials

Completed11 · 65%
Terminated2 · 12%
Unknown status2 · 12%
Recruiting1 · 6%
Active, not recruiting1 · 6%

Trial Activity

17 trials

Efficacy Study of Rectus Sheath Block to Control Postoperative Pain
Completed··Phase 4·NCT02115087·40 enrolled
Ultrasound-guided Rectus Sheath Block In Children
Completed··Phase 4·NCT02291705·40 enrolled
Rectus Sheath Block for Analgesia After Gynecological Laparotomy
Completed··Phase 4·NCT06575699·90 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)